Search Results - "DIPHOSPHONATES"

Evaluation of ¹⁶¹ Tb-Labeled Diphosphonates as Potential Bone-Targeting Agents.

Authors: Sitarica P Vukadinović A Marić M et al.

Source: International journal of molecular sciences [Int J Mol Sci] 2025 Oct 25; Vol. 26 (21). Date of Electronic Publication: 2025 Oct 25.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

MeSH Terms: Diphosphonates*/chemistry , Diphosphonates*/pharmacokinetics , Bone and Bones*/metabolism , Bone and Bones*/drug effects , Radiopharmaceuticals*/chemistry , Radiopharmaceuticals*/pharmacokinetics, Animals ; Rats ; Tissue Distribution ; Rats, Wistar ; Zoledronic Acid/chemistry ; Zoledronic Acid/pharmacokinetics ; Male ; Humans ; Etidronic Acid/chemistry ; Etidronic Acid/pharmacokinetics

Preoperative bisphosphonates in total hip arthroplasty : safe regardless of treatment duration.

Authors: Hong SH Yu YJ Han SB

Source: The bone & joint journal [Bone Joint J] 2025 Dec 01; Vol. 107-B (12), pp. 1242-1253. Date of Electronic Publication: 2025 Dec 01.

Publication Type: Journal Article

Journal Info: Publisher: British Editorial Society of Bone & Joint Surgery Country of Publication: England NLM ID: 101599229 Publication Model: Electronic Cited Medium: Internet ISSN: 2049-4408 (Electronic) Linking ISSN: 20494394 NLM ISO Abbreviation: Bone Joint J Subsets: MEDLINE

MeSH Terms: Arthroplasty, Replacement, Hip*/adverse effects , Arthroplasty, Replacement, Hip*/methods , Diphosphonates*/adverse effects , Diphosphonates*/administration & dosage , Diphosphonates*/therapeutic use , Bone Density Conservation Agents*/adverse effects , Bone Density Conservation Agents*/administration & dosage , Bone Density Conservation Agents*/therapeutic use , Postoperative Complications*/epidemiology, Humans ; Female ; Male ; Aged ; Middle Aged ; Reoperation/statistics & numerical data ; Risk Factors ; Periprosthetic Fractures/epidemiology ; Periprosthetic Fractures/etiology ; Retrospective Studies ; Preoperative Care/methods ; Republic of Korea ; Propensity Score ; Time Factors ; Databases, Factual ; Aged, 80 and over

Impact of Bisphosphonates in Hormone-sensitive Metastatic Prostate Cancer A Systematic Review and Meta-Analysis.

Authors: Polho GB Melo AAR Ornelas-Filho LC et al.

Source: Clinical genitourinary cancer [Clin Genitourin Cancer] 2025 Dec; Vol. 23 (6), pp. 102438. Date of Electronic Publication: 2025 Sep 18.

Publication Type: Journal Article; Systematic Review; Meta-Analysis; Review

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE

MeSH Terms: Diphosphonates*/therapeutic use , Diphosphonates*/adverse effects , Prostatic Neoplasms*/drug therapy , Prostatic Neoplasms*/pathology , Bone Neoplasms*/secondary , Bone Neoplasms*/drug therapy , Bone Density Conservation Agents*/therapeutic use , Bone Density Conservation Agents*/adverse effects, Humans ; Male ; Randomized Controlled Trials as Topic ; Treatment Outcome

Dual effects of bisphosphonates on bone metabolism and implant osseointegration: mechanisms, risks and clinical strategies.

Authors: Liu H Wang X Shi Y et al.

Source: Journal of stomatology, oral and maxillofacial surgery [J Stomatol Oral Maxillofac Surg] 2025 Dec; Vol. 126 (6S), pp. 102534. Date of Electronic Publication: 2025 Aug 19.

Publication Type: Journal Article; Review

Journal Info: Publisher: Elsevier Masson SAS Country of Publication: France NLM ID: 101701089 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-7855 (Electronic) Linking ISSN: 24687855 NLM ISO Abbreviation: J Stomatol Oral Maxillofac Surg Subsets: MEDLINE

MeSH Terms: Osseointegration*/drug effects , Diphosphonates*/pharmacology , Diphosphonates*/adverse effects , Bone Density Conservation Agents*/pharmacology , Bone Density Conservation Agents*/adverse effects , Dental Implants* , Bone and Bones*/metabolism , Bone and Bones*/drug effects, Humans ; Animals ; Bone Remodeling/drug effects ; Osteoclasts/drug effects

Economic impact of MAF testing for adjuvant bisphosphonate therapy in early breast cancer: a multi-regional budget impact analysis from a payer perspective.

Authors: Carapinha JL Tercero JC van den Berg R et al.

Source: Journal of medical economics [J Med Econ] 2025 Dec; Vol. 28 (1), pp. 1285-1297. Date of Electronic Publication: 2025 Aug 10.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE

MeSH Terms: Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics , Breast Neoplasms*/pathology , Bone Density Conservation Agents*/therapeutic use , Bone Density Conservation Agents*/economics , Diphosphonates*/therapeutic use , Diphosphonates*/economics , Bone Neoplasms*/secondary , Bone Neoplasms*/prevention & control , Genetic Testing*/economics, Humans ; Female ; Markov Chains ; Zoledronic Acid/therapeutic use ; Zoledronic Acid/economics ; Cost-Benefit Analysis ; Middle Aged ; Decision Trees ; Budgets ; Postmenopause ; Europe ; Chemotherapy, Adjuvant/economics ; Aged ; North America

Comparative Effects of Minodronate and Alendronate on Low Back Pain in Postmenopausal Osteoporosis and Age Influence: A Head-to-Head, Randomized Clinical Trial.

Authors: Wang H Liu H Huang J et al.

Source: Clinical interventions in aging [Clin Interv Aging] 2025 Nov 27; Vol. 20, pp. 2219-2230. Date of Electronic Publication: 2025 Nov 27 (Print Publication: 2025).

Publication Type: Journal Article; Randomized Controlled Trial; Comparative Study

Journal Info: Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101273480 Publication Model: eCollection Cited Medium: Internet ISSN: 1178-1998 (Electronic) Linking ISSN: 11769092 NLM ISO Abbreviation: Clin Interv Aging Subsets: MEDLINE

MeSH Terms: Alendronate*/therapeutic use , Alendronate*/administration & dosage , Alendronate*/adverse effects , Bone Density Conservation Agents*/therapeutic use , Bone Density Conservation Agents*/administration & dosage , Bone Density Conservation Agents*/adverse effects , Osteoporosis, Postmenopausal*/drug therapy , Osteoporosis, Postmenopausal*/complications , Low Back Pain*/drug therapy , Low Back Pain*/etiology , Diphosphonates*/therapeutic use , Diphosphonates*/administration & dosage, Humans ; Female ; Aged ; Bone Density/drug effects ; Middle Aged ; Prospective Studies ; Lumbar Vertebrae ; Age Factors ; Treatment Outcome ; Pain Measurement ; Aged, 80 and over ; Imidazoles

Discovery of Novel Selective Estrogen Receptor β (SERβ) Agonist ( S )-STO021 as an Antiosteoporosis Candidate with Dual Functions of Inhibiting Osteoclastogenesis and Activating Osteoblastogenesis.

Authors: Peng C Geng Z Jiang Z et al.

Source: Journal of medicinal chemistry [J Med Chem] 2025 Nov 13; Vol. 68 (21), pp. 22715-22737. Date of Electronic Publication: 2025 Oct 17.

Publication Type: Journal Article

Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE

MeSH Terms: Estrogen Receptor beta*/agonists , Estrogen Receptor beta*/metabolism , Osteoporosis*/drug therapy , Osteoclasts*/drug effects , Osteoclasts*/cytology , Osteoblasts*/drug effects , Osteoblasts*/cytology , Osteogenesis*/drug effects , Diphosphonates*/pharmacology , Diphosphonates*/chemistry , Diphosphonates*/therapeutic use, Animals ; Zebrafish ; Rats ; Humans ; Mice ; Female ; Rats, Sprague-Dawley ; Cell Differentiation/drug effects ; Drug Discovery ; Structure-Activity Relationship ; RAW 264.7 Cells

Anti-tumor efficacy and Vδ2 T-cell activation via EGFR antibody-drug conjugates featuring novel aminobisphosphonates.

Authors: Cuffaro D Di Gregorio L Mangini C et al.

Source: Scientific reports [Sci Rep] 2025 Nov 05; Vol. 15 (1), pp. 38774. Date of Electronic Publication: 2025 Nov 05.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

MeSH Terms: Immunoconjugates*/pharmacology , Immunoconjugates*/chemistry , Diphosphonates*/chemistry , Diphosphonates*/pharmacology , Lymphocyte Activation*/drug effects , Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/immunology , Colorectal Neoplasms*/pathology , Antineoplastic Agents*/pharmacology, Humans ; ErbB Receptors/antagonists & inhibitors ; ErbB Receptors/immunology ; ErbB Receptors/metabolism ; Cell Line, Tumor ; Cetuximab/pharmacology ; Cetuximab/chemistry ; Cell Proliferation/drug effects ; Zoledronic Acid ; Receptors, Antigen, T-Cell, gamma-delta/metabolism ; T-Lymphocytes/immunology ; T-Lymphocytes/drug effects

Encapsulating Pt NCs with an AIE effect into a metal-organic framework as a novel fluorescence nanoprobe for discriminatively detecting bisphosphonate drugs.

Authors: Du J Chen J Tong H et al.

Source: Analytical and bioanalytical chemistry [Anal Bioanal Chem] 2025 Oct; Vol. 417 (24), pp. 5571-5582. Date of Electronic Publication: 2025 Aug 30.

Publication Type: Journal Article

Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 101134327 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1618-2650 (Electronic) Linking ISSN: 16182642 NLM ISO Abbreviation: Anal Bioanal Chem Subsets: MEDLINE

MeSH Terms: Metal-Organic Frameworks*/chemistry , Fluorescent Dyes*/chemistry , Diphosphonates*/analysis , Diphosphonates*/blood , Platinum*/chemistry , Metal Nanoparticles*/chemistry, Spectrometry, Fluorescence/methods ; Limit of Detection ; Humans ; Zeolites/chemistry

Expert Perspective: How, When, and Why to Potentially Stop Antiresorptive Drugs in Osteoporosis.

Authors: Adami G Saag KG

Source: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2025 Oct; Vol. 77 (10), pp. 1294-1304. Date of Electronic Publication: 2025 May 19.

Publication Type: Journal Article; Review

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-5205 (Electronic) Linking ISSN: 23265191 NLM ISO Abbreviation: Arthritis Rheumatol Subsets: MEDLINE

MeSH Terms: Bone Density Conservation Agents*/therapeutic use , Bone Density Conservation Agents*/administration & dosage , Denosumab*/therapeutic use , Denosumab*/administration & dosage , Osteoporosis*/drug therapy , Diphosphonates*/therapeutic use , Diphosphonates*/administration & dosage , Withholding Treatment* , Osteoporotic Fractures*/prevention & control, Humans

Clinical and economic research of bone modifiers as adjuvant therapy for early breast cancer: A systematic literature review.

Authors: Wu W Zhu Y Lin H et al.

Source: Breast (Edinburgh, Scotland) [Breast] 2025 Oct; Vol. 83, pp. 104551. Date of Electronic Publication: 2025 Aug 07.

Publication Type: Journal Article; Systematic Review; Review

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE

MeSH Terms: Breast Neoplasms*/drug therapy , Breast Neoplasms*/pathology , Breast Neoplasms*/economics , Breast Neoplasms*/mortality , Bone Density Conservation Agents*/therapeutic use , Bone Density Conservation Agents*/economics , Bone Density Conservation Agents*/adverse effects , Diphosphonates*/therapeutic use , Diphosphonates*/economics , Diphosphonates*/adverse effects, Humans ; Female ; Chemotherapy, Adjuvant/economics ; Chemotherapy, Adjuvant/methods ; Cost-Benefit Analysis ; Zoledronic Acid/therapeutic use ; Zoledronic Acid/economics ; Neoplasm Recurrence, Local/prevention & control ; Clodronic Acid/therapeutic use ; Clodronic Acid/economics

Perioperative Use of Bisphosphonate and Implant Survival After Total Joint Arthroplasty.

Authors: Lin Y Gao J Zheng H et al.

Source: The Journal of arthroplasty [J Arthroplasty] 2025 Oct; Vol. 40 (10), pp. 2575-2585.e9. Date of Electronic Publication: 2025 Apr 26.

Publication Type: Journal Article; Meta-Analysis; Systematic Review

Journal Info: Publisher: Taylor and Francis Country of Publication: United States NLM ID: 8703515 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-8406 (Electronic) Linking ISSN: 08835403 NLM ISO Abbreviation: J Arthroplasty Subsets: MEDLINE

MeSH Terms: Diphosphonates*/therapeutic use , Diphosphonates*/administration & dosage , Diphosphonates*/adverse effects , Bone Density Conservation Agents*/therapeutic use , Bone Density Conservation Agents*/administration & dosage , Prosthesis Failure*/etiology , Arthroplasty, Replacement, Hip*/adverse effects, Humans ; Reoperation/statistics & numerical data ; Perioperative Care ; Periprosthetic Fractures/epidemiology ; Periprosthetic Fractures/prevention & control ; Arthroplasty, Replacement, Knee/adverse effects

The effects of Zoledronate administration routes on the reproducibility of BRONJ in rodent models: A systematic review.

Authors: Surboyo MDC El Fadhlallah PM Sato-Yamada Y et al.

Source: Bone [Bone] 2025 Oct; Vol. 199, pp. 117563. Date of Electronic Publication: 2025 Jun 11.

Publication Type: Journal Article; Systematic Review

Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 8504048 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2763 (Electronic) Linking ISSN: 18732763 NLM ISO Abbreviation: Bone Subsets: MEDLINE

MeSH Terms: Bisphosphonate-Associated Osteonecrosis of the Jaw*/pathology , Bisphosphonate-Associated Osteonecrosis of the Jaw*/diagnostic imaging , Bisphosphonate-Associated Osteonecrosis of the Jaw*/drug therapy , Diphosphonates*/administration & dosage , Diphosphonates*/adverse effects , Imidazoles*/administration & dosage , Zoledronic Acid*/administration & dosage, Animals ; Mice ; Rats ; Bone Density Conservation Agents/administration & dosage ; Disease Models, Animal ; Drug Administration Routes ; Reproducibility of Results

Addressing surgical challenges in patients with severe form of osteogenesis imperfecta and with prolonged bisphosphonate treatment: intramedullary sclerosis and technical solutions.

Authors: Jeleč Ž Primorac D Molnar V et al.

Source: International orthopaedics [Int Orthop] 2025 Oct; Vol. 49 (10), pp. 2415-2421. Date of Electronic Publication: 2025 Sep 03.

Publication Type: Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7705431 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-5195 (Electronic) Linking ISSN: 03412695 NLM ISO Abbreviation: Int Orthop Subsets: MEDLINE

MeSH Terms: Osteogenesis Imperfecta*/drug therapy , Osteogenesis Imperfecta*/surgery , Osteogenesis Imperfecta*/diagnostic imaging , Diphosphonates*/adverse effects , Diphosphonates*/therapeutic use , Diphosphonates*/administration & dosage , Bone Density Conservation Agents*/adverse effects , Bone Density Conservation Agents*/therapeutic use , Bone Density Conservation Agents*/administration & dosage, Humans ; Female ; Male ; Child ; Adolescent ; Sclerosis/chemically induced ; Child, Preschool ; Treatment Outcome ; Pamidronate ; Severity of Illness Index ; Retrospective Studies

The role of amino bisphosphonates zoledronate and alendronate in shaping immunomodulatory profile and angiogenic potential of human periodontal ligament stem cells.

Authors: Bria J Chiarella E Sovereto J et al.

Source: PloS one [PLoS One] 2025 Dec 01; Vol. 20 (12), pp. e0335744. Date of Electronic Publication: 2025 Dec 01 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

MeSH Terms: Zoledronic Acid*/pharmacology , Periodontal Ligament*/cytology , Periodontal Ligament*/drug effects , Alendronate*/pharmacology , Stem Cells*/drug effects , Stem Cells*/metabolism , Stem Cells*/cytology , Stem Cells*/immunology , Neovascularization, Physiologic*/drug effects , Diphosphonates*/pharmacology , Bone Density Conservation Agents*/pharmacology, Humans ; Cell Proliferation/drug effects ; Cells, Cultured ; Cell Movement/drug effects ; Cytokines/metabolism ; Imidazoles/pharmacology

Development of micro-sequestra and associated histological changes in tooth extraction sockets of zoledronate-treated mice.

Authors: Koizumi G Murata T Takigawa A et al.

Source: Journal of oral biosciences [J Oral Biosci] 2025 Dec; Vol. 67 (4), pp. 100710. Date of Electronic Publication: 2025 Nov 11.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101226721 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-3865 (Electronic) Linking ISSN: 13490079 NLM ISO Abbreviation: J Oral Biosci Subsets: MEDLINE

MeSH Terms: Tooth Socket*/drug effects , Tooth Socket*/pathology , Tooth Socket*/diagnostic imaging , Tooth Extraction* , Diphosphonates*/pharmacology , Imidazoles*/pharmacology , Bone Density Conservation Agents*/pharmacology , Bone Density Conservation Agents*/adverse effects , Wound Healing*/drug effects, Animals ; Zoledronic Acid ; Mice ; X-Ray Microtomography ; Male ; Molar/surgery

Comparative effects of ovariectomy and chemically induced menopause on alveolar bone healing in zoledronate-treated female mice.

Authors: Momesso NR Bacelar-Marcolino ACZ Biguetti CC et al.

Source: Bone [Bone] 2025 Dec; Vol. 201, pp. 117655. Date of Electronic Publication: 2025 Sep 24.

Publication Type: Journal Article; Comparative Study

Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 8504048 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2763 (Electronic) Linking ISSN: 18732763 NLM ISO Abbreviation: Bone Subsets: MEDLINE

MeSH Terms: Ovariectomy* , Diphosphonates*/pharmacology , Imidazoles*/pharmacology , Wound Healing*/drug effects , Alveolar Process*/drug effects , Alveolar Process*/pathology , Alveolar Process*/diagnostic imaging , Menopause*/drug effects, Animals ; Female ; Zoledronic Acid ; Mice, Inbred C57BL ; Mice ; X-Ray Microtomography ; Vinyl Compounds/pharmacology ; Cyclohexenes/pharmacology ; Bone Density Conservation Agents/pharmacology

Effect of zoledronic acid and pamidronate on renal function.

Authors: Koss K Kocek M King T et al.

Source: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2025 Dec; Vol. 31 (8), pp. 1270-1276. Date of Electronic Publication: 2024 Sep 17.

Publication Type: Journal Article

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE

MeSH Terms: Zoledronic Acid*/adverse effects , Acute Kidney Injury*/chemically induced , Acute Kidney Injury*/epidemiology , Pamidronate*/adverse effects , Bone Density Conservation Agents*/adverse effects , Bone Density Conservation Agents*/administration & dosage , Diphosphonates*/adverse effects , Kidney*/drug effects, Humans ; Retrospective Studies ; Female ; Male ; Aged ; Middle Aged ; Incidence ; Cohort Studies ; Aged, 80 and over ; Creatinine/blood

Clinical impact of bisphosphonate treatment in reducing fragility fractures in Jordan: Insights from a developing country.

Authors: Dawod MS Alswerki MN Alelaumi AF et al.

Source: Archives of osteoporosis [Arch Osteoporos] 2025 Nov 12; Vol. 20 (1), pp. 142. Date of Electronic Publication: 2025 Nov 12.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: England NLM ID: 101318988 Publication Model: Electronic Cited Medium: Internet ISSN: 1862-3514 (Electronic) NLM ISO Abbreviation: Arch Osteoporos Subsets: MEDLINE

MeSH Terms: Diphosphonates*/therapeutic use , Bone Density Conservation Agents*/therapeutic use , Osteoporotic Fractures*/prevention & control , Osteoporotic Fractures*/epidemiology , Osteoporosis*/drug therapy, Humans ; Jordan/epidemiology ; Female ; Male ; Retrospective Studies ; Aged ; Middle Aged ; Case-Control Studies ; Quality of Life ; Bone Density/drug effects ; Developing Countries ; Aged, 80 and over

A literature review and update on medications related to osteonecrosis of the jaw independent of bisphosphonates and denosumab.

Authors: Jawad N Burns M Patel V

Source: British dental journal [Br Dent J] 2025 Nov; Vol. 239 (9), pp. 613-619. Date of Electronic Publication: 2025 Nov 14.

Publication Type: Journal Article; Review

Journal Info: Publisher: British Dental Journal Country of Publication: England NLM ID: 7513219 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5373 (Electronic) Linking ISSN: 00070610 NLM ISO Abbreviation: Br Dent J Subsets: MEDLINE

MeSH Terms: Denosumab*/adverse effects , Bone Density Conservation Agents*/adverse effects , Bisphosphonate-Associated Osteonecrosis of the Jaw*/etiology , Osteonecrosis*/chemically induced , Jaw Diseases*/chemically induced , Diphosphonates*/adverse effects, Humans